Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Wondering what do you need to start investing? Discover the essential tools and knowledge required to kickstart your investment journey.
19,065 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
As AI reshapes transportation, investors compare Uber Technologies and Lyft to gauge which company is better position...
Microsoft delivered a powerful May with a 10.4% jump, but June brought a dampening mood. This article breaks down wha...
A Federal Reserve governor's message carries big weight for markets. This piece breaks down the implications of words...
A new Fed chair angles for a disciplined inflation fight and a leaner balance sheet, even as markets seek clarity. He...
SpaceX has joined the Nasdaq 100, triggering a wave of expected passive buying estimated at $27 billion as lockups un...
When a Federal Reserve chair signals a preference for policy stability over boom-and-bust cycles, it can upend how in...
Six non-AI chip makers could be poised to benefit from the AI boom, as demand broadens beyond headline AI chips. Here...
A QuidelOrtho Corp director purchases 10,000 shares amid a CFO retirement, sparking investor interest. This article e...
Robinhood has evolved from a simple trading app to a platform with broader fintech ambitions. This article explores p...
A fintech platform unveils AI-driven index construction from a single prompt, with an uncapped 1% match for new membe...
The Nasdaq has slipped into correction territory, raising questions about the next move. This guide uncovers historic...